Ahrar K - Search Results

1

Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.

Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SF. Jonasch E, et al. Among authors: ahrar k. Lancet Oncol. 2018 Oct;19(10):1351-1359. doi: 10.1016/S1470-2045(18)30487-X. Epub 2018 Sep 17. Lancet Oncol. 2018. PMID: 30236511 Free PMC article. Clinical Trial.

2

Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.

Ahrar K, Matin S, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Ahrar K, et al. J Vasc Interv Radiol. 2005 May;16(5):679-88. doi: 10.1097/01.RVI.0000153589.10908.5F. J Vasc Interv Radiol. 2005. PMID: 15872323

3

Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax.

Ahrar K, Matin S, Wallace MJ, Gupta S, Hicks ME. Ahrar K, et al. AJR Am J Roentgenol. 2005 Jul;185(1):86-8. doi: 10.2214/ajr.185.1.01850086. AJR Am J Roentgenol. 2005. PMID: 15972404

4

Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study.

Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RJ, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Matin SF, et al. Among authors: ahrar k. J Urol. 2006 Nov;176(5):1973-7. doi: 10.1016/j.juro.2006.07.016. J Urol. 2006. PMID: 17070224

5

Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors.

Ahrar K, Wallace MJ, Matin SF. Ahrar K, et al. Expert Rev Anticancer Ther. 2006 Dec;6(12):1735-44. doi: 10.1586/14737140.6.12.1735. Expert Rev Anticancer Ther. 2006. PMID: 17181487 Review.

6

Is radiofrequency ablation safe for solitary kidneys?

Jacobsohn KM, Ahrar K, Wood CG, Matin SF. Jacobsohn KM, et al. Among authors: ahrar k. Urology. 2007 May;69(5):819-23; discussion 823. doi: 10.1016/j.urology.2006.11.027. Urology. 2007. PMID: 17482911

7

Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy.

Javadi S, Matin SF, Tamboli P, Ahrar K. Javadi S, et al. Among authors: ahrar k. J Vasc Interv Radiol. 2007 Sep;18(9):1186-91. doi: 10.1016/j.jvir.2007.06.019. J Vasc Interv Radiol. 2007. PMID: 17804784

8

Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques.

Booth J, Matin SF, Ahrar K, Tamboli P, Wood CG. Booth J, et al. Among authors: ahrar k. Urol Oncol. 2008 Jan-Feb;26(1):37-42. doi: 10.1016/j.urolonc.2007.01.012. Epub 2007 Nov 26. Urol Oncol. 2008. PMID: 18190828

9

Nephron-sparing probe ablative therapy: long-term outcomes.

Matin SF, Ahrar K. Matin SF, et al. Among authors: ahrar k. Curr Opin Urol. 2008 Mar;18(2):150-6. doi: 10.1097/MOU.0b013e3282f4a869. Curr Opin Urol. 2008. PMID: 18303535 Review.

10

Patterns of intervention for renal lesions in von Hippel-Lindau disease.

Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E. Matin SF, et al. Among authors: ahrar k. BJU Int. 2008 Sep;102(8):940-5. doi: 10.1111/j.1464-410X.2008.07718.x. Epub 2008 May 15. BJU Int. 2008. PMID: 18485044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters